Improvement of cardiac function and reversal of gap junction remodeling by Neuregulin-1β in volume-overloaded rats with heart failure
- Author:
- No author available
- Journal Title:
- JOURNAL OF GERIATRIC CARDIOLOGY
- Issue:
- 2
- DOI:
- 10.3724/SP.J.1263.2012.03271
- Key Word:
- Neuregulin-1β;Cardiac function;Heart failure;Connexin 43;Gap junction;Remodeling
Abstract： Objective We performed experiments using Neuregulin-1β (NRG-1β) treatment to determine a mechanism for the protective role derived from its beneficial effects by remodeling gap junctions (GJs) during heart failure (HF). Methods Rat models of HF were established by aortocaval fistula. Forty-eight rats were divided randomly into the HF (HF, n = 16), NRG-1β treatment (NRG, n = 16), and sham operation (S, n = 16) group. The rats in the NRG group were administered NRG-1β (10 μg/kg per day) for 7 days via the tail vein, whereas the other groups were injected with the same doses of saline. Twelve weeks after operation, Connexin 43 (Cx43) expression in single myocytes obtained from the left ventricle was determined by immunocytochemistry. Total protein was extracted from frozen left ventricular tissues for immunoblotting assay, and the ultrastructure of myocytes was observed by transmission electron microscopy. Results Compared with the HF group, the cardiac function of rats in the NRG group was markedly improved, irregular distribution and deceased Cx43 expression were relieved. The ultrastructure of myocytes was seriously damaged in HF rats, and NRG-1β reduced these pathological damages. Conclusions Short-term NRG-1β treatment can rescue pump failure in experimental models of volume overload-induced HF, which is related to the recovery of GJs structure and the improvement of Cx43 expression.
- [1]Yang C,Cui W,Pei WN,etc.Statin therapy shortens QTc, QTcd, and improves cardiac function in patients with chronic heart failure.[J].2010,140(2).
- [2]G, Isenberg,U, Klockner.Calcium tolerant ventricular myocytes prepared by preincubation in a "KB medium".[J].1982,395(1).
- [3]R, Garcia,S, Diebold.Simple, rapid, and effective method of producing aortocaval shunts in the rat.[J].1990,24.
- [4]Chen FL,Liu F,Fishman GI,etc.Heterogeneous expression of Gap junction channels in the heart leads to conduction defects and ventricular dysfunction.[J].2001,104(10).
- [5]D A, Siwik,J D, Tzortzis,D R, Pimental,etc.Inhibition of copper-zinc superoxide dismutase induces cell growth, hypertrophic phenotype, and apoptosis in neonatal rat cardiac myocytes in vitro.[J].1999,85.
- [6]Cingolani E,Akar FG,Nass RD,etc.Dynamic changes in conduction velocity and gap junction properties during development of pacing-induced heart failure.[J].2007,293(2).
- [7]P, Davey.QT interval lengthening in cardiac disease relates more to left ventricular systolic dysfunction than to autonomic function.[J].2000,2(3).
- [8]Fukazawa R,Kim YD,Miller TA,etc.Neuregulin-1 protects ventricular myocytes from anthracycline-induced apoptosis via erbB4-dependent activation of PI3-kinase/Akt.[J].2003,35(12).
- [9]A K, Dhalla,M F, Hill,P K, Singal.Role of oxidative stress in transition of hypertrophy to heart failure.[J].1996,28(2).
- [10]Timolati F,Suter TM,Zuppinger C,etc.Neuregulin-1 beta attenuates doxorubicin-induced alterations of excitation-contraction coupling and reduces oxidative stress in adult rat cardiomyocytes.[J].2006,41(5).
- [11]England JF,Liu X,Amor R,etc.Parenteral administration of recombinant human neuregulin-1 to patients with stable chronic heart failure produces favourable acute and chronic haemodynamic responses.[J].2011,13(1).
- [12]Yu Liu,He Huang,Wenfang Xia,etc.Inhibition of NADPH oxidase up-regulates connexin 43 and ameliorates electrical remodeling in rabbits with heart failure[J].2011,1(1).
- [13]Jiao Z,Gourdie RG,Iravanian S,etc.Inhibition of renin-angiotensin system (RAS) reduces ventricular tachycardia risk by altering connexin43.[J].2011,89(7).
- [14]Cooke CA,Shah MH,Halperin VL,etc.Ultrastructure and regulation of lateralized connexin43 in the failing heart.[J].2010,106(6).
- [15]Klimas J,Kmecova J.Heart rate correction of the QT duration in rats.[J].2010,641(2).
- [16]Sawyer DB.Oxidative stress in heart failure: what are we missing?[J].2011,342(2).
- [17]Dupont E,Severs NJ,Bruce AF,etc.Remodelling of gap junctions and connexin expression in diseased myocardium.[J].2008,80(1).
- [18]Neil J, Freedman,Geoffrey S, Ginsburg.Novel--and "neu"--therapeutic possibilities for heart failure.[J].2006,48(7).
- [19]Sawyer DB,Guo X,Kuramochi Y.Neuregulin activates erbB2-dependent src/FAK signaling and cytoskeletal remodeling in isolated adult rat cardiac myocytes.[J].2006,41(2).
- [20]K F, Lee,H, Simon,H, Chen,etc.Requirement for neuregulin receptor erbB2 in neural and cardiac development.[J].1995,378(6555).
- [21]N S, Peters,C R, Green,P A, Poole-Wilson,etc.Reduced content of connexin43 gap junctions in ventricular myocardium from hypertrophied and ischemic human hearts.[J].1993,88.
- [22]Liu FF,Stone JR,Schuldt AJ,etc.Heterozygous knockout of neuregulin-1 gene in mice exacerbates doxorubicin-induced heart failure.[J].2005,289(2).
- [23]S. Britsch.The Neuregulin-1/ErbB Signaling System in Development and Disease[J].2007,190(0).
- [24]Ramella R,Gallo MP,Fitou A,etc.Neuregulin-1beta1 rapidly modulates nitric oxide synthesis and calcium handling in rat cardiomyocytes.[J].2010,88(3).
- [25]Lemmens K,Segers VF,Demolder M,etc.Role of neuregulin-1/ErbB2 signaling in endothelium-cardiomyocyte cross-talk.[J].2006,281(28).